Pallas Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Buy
+39,816
New +$435K 0.01% 627
2026
Q1
– Sell
-39,036
Closed -$446K – 982
2025
Q4
$446K Sell
39,036
-43,485
-53% -$510K 0.01% 570
2025
Q3
$1.05M Buy
82,521
+350
+0.4% +$5.08K 0.04% 338
2025
Q2
$1.3M Buy
82,171
+37,306
+83% +$558K 0.05% 271
2025
Q1
$670K Buy
44,865
+30,953
+222% +$548K 0.03% 390
2024
Q4
$264K Buy
+13,912
New +$294K 0.01% 495

Other funds holding XRAY

Pallas Capital Advisors's XRAY Position: Q2 2026 in Review

Pallas Capital Advisors opened a new position in Dentsply Sirona (XRAY) in Q2 2026: 39,816 shares worth $422K. The stake represents 0.01% of the portfolio and ranks #627 among its holdings. This is a return to the name: Pallas Capital Advisors previously reported a position in XRAY as recently as Q4 2025.

Pallas Capital Advisors first reported a position in XRAY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.3M in Q2 2025. 377 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Pallas Capital Advisors held 39,816 shares of Dentsply Sirona worth $422K as of Q2 2026.
  • Dentsply Sirona was a new Pallas Capital Advisors position in Q2 2026.
  • Dentsply Sirona made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #627 holding.
  • Pallas Capital Advisors first reported a position in Dentsply Sirona in Q4 2024 and has held it in 6 quarters since.
  • Pallas Capital Advisors's Dentsply Sirona position peaked at $1.3M in Q2 2025.
  • 377 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.